FREE Case Review (866) 588-0600

Nebraska Tylenol Autism Lawsuit: Get the Right Attorney

Award Logos
Awards & recognition
C.L. Mike Schmidt Published by C.L. Mike Schmidt

The Tylenol Autism Lawsuit in Nebraska has ignited a crucial legal debate, focusing on the possible connection between Tylenol use and the development of autism spectrum disorder (ASD) or attention deficit hyperactivity disorder (ADHD).

At Schmidt and Clark, we are committed to shedding light on this complex topic, offering guidance and expertise to those affected. Understanding the intertwining medical and legal aspects of Tylenol use is essential for families in Nebraska facing these challenges.

If your family is affected by the issues raised in Tylenol Autism Lawsuits in Nebraska And you are considering legal action, don't hesitate to reach out to us. Schmidt and Clark offer a free consultation to evaluate your situation with compassion and proficiency.

Tylenol, Autism and ADHD

The possible link between prenatal Tylenol exposure and the onset of autism or ADHD has initiated extensive research and legal proceedings. Numerous studies have suggested that acetaminophen exposure during pregnancy may contribute to an increased risk of having a baby with ASD, ADHD, or other developmental disorders.

This has led to a surge in Tylenol autism lawsuits, as affected families seek compensation for the challenges they face. Medically, pregnant women using acetaminophen have an elevated risk of birthing infants with conditions like ASD and ADHD.

These developmental disorders can have a long-term impact on a child’s life. Legally, the plaintiffs argue that not alerting people about potential health hazards has harmed affected children, and they are at present handling multiple Tylenol autism lawsuits for families unaware of the autism risk associated with prenatal acetaminophen use.

The Tylenol autism lawsuits in Nebraska have implications like heightened awareness about the possible perils of prenatal acetaminophen use and the potential financial burdens of raising a child with autism spectrum disorder.

Advocates in the autism community are hopeful that reduced exposure to acetaminophen in the womb will lower the incidence of ASD and ADHD. In light of these concerns, acetaminophen autism lawsuits are becoming more prevalent.

Legal practitioners, like Nebraska Tylenol autism lawyers, provide a range of services including:

  • Complimentary consultation to assist individuals in ascertaining the viability of their case
  • Leading them through legal procedures
  • Reviewing Tylenol autism lawsuits
  • Supporting affected families in fighting for justice.

Tylenol Autism Lawsuit in Nebraska

The Tylenol autism lawsuit in Nebraska alleges that Johnson & Johnson neglected to apprise consumers of the potential risks associated with utilizing Tylenol during pregnancy, purportedly resulting in an augmented risk of autism and ADHD in children.

The lawsuit alleges that J&J knew or should have known about the increased ASD and ADHD risk from acetaminophen, but they still marketed the drug as safe for use during pregnancy, ignoring contradicting evidence.

As of November 16, 2023, 441 tylenol autism cases were pending in multidistrict litigation (tylenol autism MDL), including the notable tylenol autism case. These cases are advancing through the discovery stage, with legal representatives gathering scientific data from experts on Tylenol and autism.

This process consolidates similar lawsuits under one court overseen by one judge, allowing plaintiffs and lawyers to share resources and information, and expediting the legal process.

A Tylenol autism lawyer can:

  • Scrutinize your acetaminophen autism lawsuit
  • Determine the damages you can claim
  • Advocate for your interests in negotiations or court
  • Provide legal counsel drawn from their experience with similar clients
  • Guide whether an individual meets the criteria to initiate legal action
  • Review their medical records and history of acetaminophen exposure

Scientific Groundwork: Linking Tylenol to Neurodevelopmental Issues

Several studies have identified a link between prenatal exposure to acetaminophen, the active ingredient in Tylenol, and a heightened risk of ADHD in children, forming a scientific foundation for the lawsuits. Research has indicated that prenatal exposure to Tylenol may increase the risk of autism in children.

A study conducted in 2020 involved analyzing 132,738 mother and child pairs. The results showed that prolonged exposure to acetaminophen could cause a 20% increased risk of autism and a 30% higher risk of ADHD [1].

Another noteworthy study, the Boston Birth Cohort study, revealed a link between Tylenol use and neurological disorders in children. In this study, 25.8% of the children were diagnosed with ADHD and 6.6% with an autism spectrum disorder. These diagnoses have contributed to the increasing number of Tylenol lawsuits [2].

A 2019 Johns Hopkins University study found that:

  • The amount of acetaminophen present in blood samples correlated with increased risks of autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD).
  • Higher levels of acetaminophen in children correlated with an increase in ADHD and ASD diagnoses.
  • The likelihood of having an ADHD diagnosis was estimated to be 2.26 times greater.
  • The likelihood of having an ASD diagnosis was 2.14 times greater.

It’s posited that Tylenol’s active ingredient is an endocrine disruptor, potentially leading to unexpected outcomes in infants exposed prenatally to Tylenol or generic acetaminophen, such as genital malformations at birth, reduced sperm count in males, or early puberty in females. These outcomes may also be linked to an autism spectrum disorder diagnosis.

The scientific community is gathering more data showing a robust correlation between prenatal exposure to Tylenol (and generic acetaminophen) and an increased likelihood that the offspring will develop autism spectrum disorder (ASD) or other autism spectrum disorders.

This growing body of evidence provides a foundation for the numerous Tylenol autism lawsuits filed against the manufacturer.

Nebraska’s legal process involves multidistrict litigation, which groups together similar lawsuits to speed up the process and enable plaintiffs and lawyers to share resources and information. This process can facilitate the legal process in Nebraska by:

  • Consolidating the pretrial process
  • Motivating parties to achieve a swifter resolution of complex cases
  • Streamlining the proceedings
  • Avoiding redundant efforts

There are advantages and disadvantages to the multidistrict litigation process for plaintiffs in Nebraska. The advantages include the coordination and consolidation of pretrial proceedings for effective case management and the removal of cases to federal court, which may have certain benefits. However, there may be a diminishment of autonomy for plaintiffs in the MDL process.

Even with the case consolidation in multidistrict litigation, plaintiffs still keep their product liability lawyers to represent them in the process. These attorneys assist in navigating the complex legal landscape of Nebraska, helping plaintiffs to build a strong case and pursue justice for their children affected by autism or ADHD.

Client Guidance: Filing a Lawsuit in Nebraska

For individuals to file a Tylenol autism lawsuit in Nebraska, they must satisfy certain criteria, including a diagnosis of ADHD or ASD and prenatal acetaminophen exposure. It is essential to work with experienced product liability attorneys who can guide whether an individual meets these criteria and can assist in building a strong case.

It is important to consult with a competent attorney when filing a Tylenol autism lawsuit. This should be the initial step taken. These attorneys will:

  • Evaluate the case
  • Review medical records and history of acetaminophen exposure
  • Provide legal counsel concerning the potential lawsuit
  • Guide plaintiffs through the complex process of multidistrict litigation
  • Ensure a timely filing within the statute of limitations.

Beyond assisting individuals in determining case viability, a Tylenol autism lawyer can help with the following:

  • Completing required documents, like the Plaintiff Fact Sheet, which contains questions about eligibility and the plaintiff’s medical history
  • Navigating the legal landscape in Nebraska
  • Seeking justice for their children affected by autism or ADHD

By working closely with your attorney, plaintiffs can receive the necessary support and guidance throughout the legal process.

Statute of Limitations

The statute of limitations for filing a Tylenol autism lawsuit in Nebraska can differ, emphasizing the need to consult with a well-informed attorney to guarantee timely filing.

The legal time limit for filing pharmaceutical lawsuits in Nebraska is typically four years from the date of the injury or from the date the injury was discovered, whichever is earlier.

However, there may be exceptions or extensions to this time limit based on the particular circumstances of the case, such as the discovery rule, which is an equitable tolling doctrine applied to the statute of limitations in Nebraska.

Consulting with an experienced attorney can provide clarity on the statute of limitations and help plaintiffs navigate any potential exemptions or extensions to ensure their case is filed within the appropriate time frame.

Related Articles:

See all related dangerous drugs lawsuits our lawyers covered so far.


  1. "Tylenol (Acetaminophen) Use During Pregnancy and Child Neurodevelopmental Outcomes"
  2. "Association Between Acetaminophen Use During Pregnancy and Autism Spectrum Disorder in Childhood: A Population-Based Study Using a Validated Exposure Assessment Tool"